Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: the place of rituximab and plasma exchange?

Abstract Objective The optimal induction therapy for severe glomerulonephritis of ANCA-associated vasculitis (AAV) is debated. We compared the efficacy of glucocorticoid and rituximab (RTX) or CYC induction therapy for severe AAV-related glomerulonephritis and evaluated the potential benefit of plas...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Rheumatology 2022-10, Vol.61 (10), p.4056-4064
Hauptverfasser:	Morel, Pauline, Karras, Alexandre, Porcher, Raphaël, Belenfant, Xavier, Audard, Vincent, Rafat, Cédric, Hanouna, Guillaume, Beaudreuil, Séverine, Vilain, Cédric, Hummel, Aurélie, Terrier, Benjamin, Pillebout, Evangeline, Groh, Matthieu, Jouenne, Romain, Dhote, Robin, Fain, Olivier, Ponsoye, Matthieu, Noel, Nicolas, Limal, Nicolas, Puéchal, Xavier, Le Jeunne, Claire, Guillevin, Loïc, Mouthon, Luc, Régent, Alexis
Format:	Artikel
Sprache:	eng
Schlagworte:	Human health and pathology Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!